{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:09Z","timestamp":1789560129187,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2024053"],"award-info":[{"award-number":["A2024053"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018598","name":"Guangdong Esophageal Cancer Research Institute","doi-asserted-by":"publisher","award":["Q201909"],"award-info":[{"award-number":["Q201909"]}],"id":[{"id":"10.13039\/501100018598","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04454-4","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:52:27Z","timestamp":1781931147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell and multi-omics integration delineates the landscape of gene-wise intratumor heterogeneity and identifies prognostic biomarkers for immunotherapy in non-small cell lung cancer"],"prefix":"10.1007","volume":"75","author":[{"given":"Jianye","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelin","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuishen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"3","key":"4454_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4454_CR2","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Vaccarella S, Morgan E, Li M, Etxeberria J, Chokunonga E, Manraj SS, Kamate B, Omonisi A, Bray F (2023) Global variations in lung cancer incidence by histological subtype in 2020: a population-based study. Lancet Oncol 24(11):1206\u20131218","journal-title":"Lancet Oncol"},{"issue":"21","key":"4454_CR3","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, Felip E, Broderick SR, Brahmer JR, Swanson SJ et al (2022) Neoadjuvant Nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med 386(21):1973\u20131985","journal-title":"N Engl J Med"},{"issue":"22","key":"4454_CR4","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi L, Rodr\u00edguez-Abreu D, Gadgeel S, Esteban E, Felip E, De Angelis F, Domine M, Clingan P, Hochmair MJ, Powell SF et al (2018) Pembrolizumab plus chemotherapy in metastatic non\u2013small-cell lung cancer. N Engl J Med 378(22):2078\u20132092","journal-title":"N Engl J Med"},{"issue":"7","key":"4454_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1470-2045(19)30167-6","volume":"20","author":"H West","year":"2019","unstructured":"West H, McCleod M, Hussein M, Morabito A, Rittmeyer A, Conter HJ, Kopp HG, Daniel D, McCune S, Mekhail T et al (2019) Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 20(7):924\u2013937","journal-title":"Lancet Oncol"},{"issue":"14","key":"4454_CR6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, Reinmuth N, Vergnenegre A, Barrios CH, Morise M, Felip E, Andric Z, Geater S et al (2020) Atezolizumab for first-line treatment of PD-L1\u2013selected patients with NSCLC. N Engl J Med 383(14):1328\u20131339","journal-title":"N Engl J Med"},{"key":"4454_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01260-z","author":"L Horvath","year":"2020","unstructured":"Horvath L, Thienpont B, Zhao L, Wolf D, Pircher A (2020) Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC)\u2014novel approaches and future outlook. Mol Cancer. https:\/\/doi.org\/10.1186\/s12943-020-01260-z","journal-title":"Mol Cancer"},{"issue":"4","key":"4454_CR8","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld AJ, Hellmann MD (2020) Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37(4):443\u2013455","journal-title":"Cancer Cell"},{"key":"4454_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22801-0","author":"F Wu","year":"2021","unstructured":"Wu F, Fan J, He Y, Xiong A, Yu J, Li Y, Zhang Y, Zhao W, Zhou F, Li W et al (2021) Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-021-22801-0","journal-title":"Nat Commun"},{"key":"4454_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2022.100165","author":"H-J Wu","year":"2022","unstructured":"Wu H-J, Temko D, Maliga Z, Moreira AL, Sei E, Minussi DC, Dean J, Lee C, Xu Q, Hochart G et al (2022) Spatial intra-tumor heterogeneity is associated with survival of lung adenocarcinoma patients. Cell Genomics. https:\/\/doi.org\/10.1016\/j.xgen.2022.100165","journal-title":"Cell Genomics"},{"issue":"7957","key":"4454_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","volume":"616","author":"AM Frankell","year":"2023","unstructured":"Frankell AM, Dietzen M, Al Bakir M, Lim EL, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A et al (2023) The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 616(7957):525\u2013533","journal-title":"Nature"},{"issue":"4","key":"4454_CR12","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk A, Janiszewska M, Polyak K (2020) Intratumor heterogeneity: the Rosetta stone of therapy resistance. Cancer Cell 37(4):471\u2013484","journal-title":"Cancer Cell"},{"key":"4454_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01143-6","author":"C Yang","year":"2022","unstructured":"Yang C, Zhang S, Cheng Z, Liu Z, Zhang L, Jiang K, Geng H, Qian R, Wang J, Huang X et al (2022) Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer. Genome Med. https:\/\/doi.org\/10.1186\/s13073-022-01143-6","journal-title":"Genome Med"},{"issue":"10","key":"4454_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41591-019-0595-z","volume":"25","author":"D Biswas","year":"2019","unstructured":"Biswas D, Birkbak NJ, Rosenthal R, Hiley CT, Lim EL, Papp K, Boeing S, Krzystanek M, Djureinovic D, La Fleur L et al (2019) A clonal expression biomarker associates with lung cancer mortality. Nat Med 25(10):1540\u20131548","journal-title":"Nat Med"},{"issue":"8","key":"4454_CR15","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, Bassez A, Decaluw\u00e9 H, Pircher A, Van den Eynde K et al (2018) Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med 24(8):1277\u20131289","journal-title":"Nat Med"},{"issue":"7693","key":"4454_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R et al (2018) TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"issue":"9","key":"4454_CR17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, Kim K-M, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M et al (2018) Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med 24(9):1449\u20131458","journal-title":"Nat Med"},{"issue":"2","key":"4454_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M et al (2019) Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy. Cancer Cell 35(2):238-255.e236","journal-title":"Cancer Cell"},{"key":"4454_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48700-8","author":"M De Zuani","year":"2024","unstructured":"De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, Curras-Alonso S, Hadjipanayis A, Athanasiadis EI, Gerstung M et al (2024) Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-024-48700-8","journal-title":"Nat Commun"},{"issue":"2","key":"4454_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2023","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C et al (2023) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42(2):293\u2013304","journal-title":"Nat Biotechnol"},{"issue":"4","key":"4454_CR21","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, Irizarry RA (2022) Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol 40(4):517\u2013526","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4454_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287","journal-title":"OMICS"},{"issue":"1","key":"4454_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautes-Fridman C, Fridman WH et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17(1):218","journal-title":"Genome Biol"},{"key":"4454_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS (2021) OncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbab260","journal-title":"Brief Bioinform"},{"issue":"1","key":"4454_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2024","unstructured":"Jin S, Plikus MV, Nie Q (2024) CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics. Nat Protoc 20(1):180\u2013219","journal-title":"Nat Protoc"},{"issue":"6476","key":"4454_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati GS, Sikandar SS, Wesche DJ, Manjunath A, Bharadwaj A, Berger MJ, Ilagan F, Kuo Angera H, Hsieh RW, Cai S et al (2020) Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367(6476):405\u2013411","journal-title":"Science"},{"issue":"5","key":"4454_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, Kumar T, Hu M, Sei E, Davis A et al (2021) Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39(5):599\u2013608","journal-title":"Nat Biotechnol"},{"issue":"10","key":"4454_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010576","volume":"18","author":"W Gasper","year":"2022","unstructured":"Gasper W, Rossi F, Ligorio M, Ghersi D (2022) Variant calling enhances the identification of cancer cells in single-cell RNA sequencing data. PLoS Comput Biol 18(10):e1010576","journal-title":"PLoS Comput Biol"},{"issue":"D1","key":"4454_CR29","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, Wu J, Tang H, Zheng S, Liu Y et al (2025) Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res 53(D1):D1670\u2013D1676","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4454_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccell.2022.02.002","volume":"40","author":"NS Patil","year":"2022","unstructured":"Patil NS, Nabet BY, M\u00fcller S, Koeppen H, Zou W, Giltnane J, Au-Yeung A, Srivats S, Cheng JH, Takahashi C et al (2022) Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer. Cancer Cell 40(3):289","journal-title":"Cancer Cell"},{"key":"4454_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01164-9","author":"J Hu","year":"2023","unstructured":"Hu J, Zhang L, Xia H, Yan Y, Zhu X, Sun F, Sun L, Li S, Li D, Wang J et al (2023) Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Medicine. https:\/\/doi.org\/10.1186\/s13073-023-01164-9","journal-title":"Genome Medicine"},{"issue":"1","key":"4454_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"BL Liu","year":"2022","unstructured":"Liu BL, Hu XD, Feng KC, Gao RR, Xue ZQ, Zhang SJ, Zhang YY, Corse E, Hu Y, Han WD et al (2022) Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nature Cancer 3(1):108","journal-title":"Nature Cancer"},{"key":"4454_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.018","author":"ZD Liu","year":"2025","unstructured":"Liu ZD, Yang ZL, Wu JQ, Zhang WJ, Sun YX, Zhang C, Bai GY, Yang L, Fan HT, Chen YW et al (2025) A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer. Cell. https:\/\/doi.org\/10.1016\/j.cell.2025.03.018","journal-title":"Cell"},{"key":"4454_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110122","volume":"87","author":"L Xie","year":"2021","unstructured":"Xie L, Zhu G, Shang J, Chen X, Zhang C, Ji X, Zhang Q, Wei Y (2021) An overview on the biological activity and anti-cancer mechanism of lovastatin. Cell Signal 87:110122","journal-title":"Cell Signal"},{"issue":"2","key":"4454_CR35","doi-asserted-by":"publisher","first-page":"12509","DOI":"10.1080\/21655979.2021.2009415","volume":"12","author":"Y Cai","year":"2021","unstructured":"Cai Y, Zhao F (2021) Fluvastatin suppresses the proliferation, invasion, and migration and promotes the apoptosis of endometrial cancer cells by upregulating Sirtuin 6 (SIRT6). Bioengineered 12(2):12509\u201312520","journal-title":"Bioengineered"},{"issue":"7","key":"4454_CR36","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","volume":"24","author":"AM Holder","year":"2024","unstructured":"Holder AM, Dedeilia A, Sierra-Davidson K, Cohen S, Liu D, Parikh A, Boland GM (2024) Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nat Rev Cancer 24(7):498\u2013512","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"4454_CR37","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s43018-022-00433-7","volume":"3","author":"BL Liu","year":"2022","unstructured":"Liu BL, Zhang YY, Wang DF, Hu XD, Zhang ZM (2022) Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade. Nat Cancer 3(9):1123","journal-title":"Nat Cancer"},{"issue":"12","key":"4454_CR38","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.1172\/JCI123360","volume":"128","author":"JD Klement","year":"2018","unstructured":"Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, Celis E, Abrams SI, Ozato K, Liu K (2018) An osteopontin\/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest 128(12):5549\u20135560","journal-title":"J Clin Invest"},{"issue":"2","key":"4454_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.trecan.2024.11.005","volume":"11","author":"PSW Cheng","year":"2025","unstructured":"Cheng PSW, Zaccaria M, Biffi G (2025) Functional heterogeneity of fibroblasts in primary tumors and metastases. Trends in Cancer 11(2):135\u2013153","journal-title":"Trends in Cancer"},{"key":"4454_CR40","doi-asserted-by":"publisher","first-page":"S1243","DOI":"10.1016\/j.annonc.2024.08.2295","volume":"35","author":"N Girard","year":"2024","unstructured":"Girard N, Burotto M, Paz-Ares LG, Reck M, Schenker M, Lingua A, Orlandi FJ, Naidoo J, Beardlsey EK, Velcheti V et al (2024) LBA53 Nivolumab (NIVO) plus relatlimab with platinum-doublet chemotherapy (PDCT) vs NIVO + PDCT as first-line (1L) treatment (tx) for stage IV or recurrent NSCLC: results from the randomized phase II RELATIVITY-104 study. Ann Oncol 35:S1243\u2013S1244","journal-title":"Ann Oncol"},{"issue":"16","key":"4454_CR41","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1158\/1078-0432.CCR-25-0806","volume":"31","author":"D Davar","year":"2025","unstructured":"Davar D, Eroglu Z, Milhem M, Becerra C, Gutierrez M, Ribas A, Di Pace B, Wang T, Zhang H, Ghosh S et al (2025) Combined targeting of PD-1 and TIM-3 in patients with locally advanced or metastatic non\u2013small cell lung cancer: AMBER Part 2B. Clin Cancer Res 31(16):3443\u20133451","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4454_CR42","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen DS, Koelzer VH, Herzig P, Roller A, Trefny M, Dimeloe S, Kiialainen A, Hanhart J, Schill C, Hess C et al (2018) A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat Med 24(7):994","journal-title":"Nat Med"},{"key":"4454_CR43","doi-asserted-by":"crossref","unstructured":"Zhou YB, Han C, Li DL, Yu ZJ, Li FM, Li F, An Q, Bai HL, Zhang XJ, Duan ZF et al (2015) Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growth. Sci Rep-Uk. 5.","DOI":"10.1038\/srep10433"},{"key":"4454_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1569271","author":"XJ Fang","year":"2025","unstructured":"Fang XJ, Yang JH, Yang L, Lin YY, Li YY, Yin X, Dou XB, Miao CY (2025) Multi-omics analysis identified macrophages as key contributors to sex-related differences in ulcerative colitis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1569271","journal-title":"Front Immunol"},{"key":"4454_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00677-3","author":"JY Qu","year":"2021","unstructured":"Qu JY, Li J, Zhang YM, He RZ, Liu XT, Gong K, Duan LL, Luo WH, Hu Z, Wang GS et al (2021) AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K\/AKT\/NF-\u03baB signaling pathway. Cell Biosci. https:\/\/doi.org\/10.1186\/s13578-021-00677-3","journal-title":"Cell Biosci"},{"issue":"17","key":"4454_CR46","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1158\/1078-0432.CCR-23-3980","volume":"30","author":"KN Suvilesh","year":"2024","unstructured":"Suvilesh KN, Manjunath Y, Nussbaum YI, Gadelkarim M, Raju M, Srivastava A, Li GF, Warren WC, Shyu CR, Gao F et al (2024) Targeting AKR1B10 by drug repurposing with Epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids. Clin Cancer Res 30(17):3855\u20133867","journal-title":"Clin Cancer Res"},{"key":"4454_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07035-4","author":"C Xiang","year":"2024","unstructured":"Xiang C, Chen L, Zhu SL, Chen Y, Huang HD, Yang CM, Chi YG, Wang YZ, Lei YL, Cai XW (2024) CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer. Cell Death Dis. https:\/\/doi.org\/10.1038\/s41419-024-07035-4","journal-title":"Cell Death Dis"},{"issue":"5","key":"4454_CR48","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.4049\/jimmunol.1003626","volume":"186","author":"W Zhao","year":"2011","unstructured":"Zhao W, Wang L, Zhang M, Wang P, Zhang L, Yuan C, Qi J, Qiao Y, Kuo PC, Gao C (2011) NF-kappaB- and AP-1-mediated DNA looping regulates osteopontin transcription in endotoxin-stimulated murine macrophages. J Immunol 186(5):3173\u20133179","journal-title":"J Immunol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04454-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:01Z","timestamp":1789556581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04454-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4454"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04454-4","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"221"}}